Terminated PHASE3 INTERVENTIONAL 2-arm NCT01487499

Bronchoscopic Intratumoral Chemotherapy for Small Cell Lung Cancer (SCLC) (SCLC)

Bronchoscopic Intratumoral Chemotherapy for Small Cell Lung Cancer

Sponsor: University of Florida

Interventions Cisplatin

Updated 8 times since 2017 Last updated: May 15, 2015 Started: Dec 31, 2011 Primary completion: Mar 31, 2015 Completion: Mar 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Unable to enroll adequate number of participants

Other terminated trials from University of Florida

See all terminations from University of Florida

Other Small Cell Lung Cancer trials with similar outcome

Browse all Small Cell Lung Cancer trials

This PHASE3 trial investigates Small Cell Lung Cancer and is currently terminated or withdrawn. University of Florida leads this study, which shows 8 recorded versions since 2011 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE3
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE3
Jan 2023 — Jul 2024 [monthly]

Terminated PHASE3
Dec 2022 — Jan 2023 [monthly]

Terminated PHASE3
Jan 2021 — Dec 2022 [monthly]

Terminated PHASE3

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Terminated PHASE3
Feb 2017 — Jun 2018 [monthly]

Terminated PHASE3
Jan 2017 — Feb 2017 [monthly]

Terminated PHASE3

First recorded

Dec 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Florida

Data source: University of Florida

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Gainesville, United States